109 related articles for article (PubMed ID: 22589488)
1. Global methylation profiling for risk prediction of prostate cancer.
Mahapatra S; Klee EW; Young CY; Sun Z; Jimenez RE; Klee GG; Tindall DJ; Donkena KV
Clin Cancer Res; 2012 May; 18(10):2882-95. PubMed ID: 22589488
[TBL] [Abstract][Full Text] [Related]
2. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
3. Next generation biomarkers in prostate cancer.
Locke JA; Black PC
Front Biosci (Landmark Ed); 2016 Jan; 21(2):328-42. PubMed ID: 26709776
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression.
Montani M; Hermanns T; Müntener M; Wild P; Sulser T; Kristiansen G
Virchows Arch; 2013 Apr; 462(4):437-43. PubMed ID: 23503867
[TBL] [Abstract][Full Text] [Related]
5. The mutational landscape of lethal castration-resistant prostate cancer.
Grasso CS; Wu YM; Robinson DR; Cao X; Dhanasekaran SM; Khan AP; Quist MJ; Jing X; Lonigro RJ; Brenner JC; Asangani IA; Ateeq B; Chun SY; Siddiqui J; Sam L; Anstett M; Mehra R; Prensner JR; Palanisamy N; Ryslik GA; Vandin F; Raphael BJ; Kunju LP; Rhodes DR; Pienta KJ; Chinnaiyan AM; Tomlins SA
Nature; 2012 Jul; 487(7406):239-43. PubMed ID: 22722839
[TBL] [Abstract][Full Text] [Related]
6. Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.
Litovkin K; Joniau S; Lerut E; Laenen A; Gevaert O; Spahn M; Kneitz B; Isebaert S; Haustermans K; Beullens M; Van Eynde A; Bollen M
J Cancer Res Clin Oncol; 2014 Nov; 140(11):1849-61. PubMed ID: 24938434
[TBL] [Abstract][Full Text] [Related]
7. The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery.
Samaržija I
Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38255186
[TBL] [Abstract][Full Text] [Related]
8. FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer.
Tong F; Lu G; Zang J; Hao D; Xu W; Chen J; Ding Q; Xiong H
J Int Med Res; 2023 Nov; 51(11):3000605231211771. PubMed ID: 37987640
[TBL] [Abstract][Full Text] [Related]
9. Methylation of hypoxia-inducible factor 3 subunit alpha contributes to poor prognosis in lung adenocarcinoma.
Shi Q; Zheng X; Hu Y; Zhou Z; Fang M; Huang X
J Appl Genet; 2023 Dec; 64(4):769-777. PubMed ID: 37707680
[TBL] [Abstract][Full Text] [Related]
10. Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers.
Rafikova G; Gilyazova I; Enikeeva K; Pavlov V; Kzhyshkowska J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628978
[TBL] [Abstract][Full Text] [Related]
11. Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution.
Imamura J; Ganguly S; Muskara A; Liao RS; Nguyen JK; Weight C; Wee CE; Gupta S; Mian OY
Front Endocrinol (Lausanne); 2023; 14():1191311. PubMed ID: 37455903
[TBL] [Abstract][Full Text] [Related]
12. Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer.
Creighton CJ; Zhang F; Zhang Y; Castro P; Hu R; Islam M; Ghosh S; Ittmann M; Kwabi-Addo B
Epigenetics; 2023 Dec; 18(1):2180585. PubMed ID: 37279148
[TBL] [Abstract][Full Text] [Related]
13. Kruppel-family zinc finger proteins as emerging epigenetic biomarkers in head and neck squamous cell carcinoma.
Pearson P; Smith K; Sood N; Chia E; Follett A; Prystowsky MB; Kirby S; Belbin TJ
J Otolaryngol Head Neck Surg; 2023 May; 52(1):41. PubMed ID: 37254212
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PANTR1 is Associated with Poor Prognostic and Suppresses Apoptosis in Glioma.
Shi F; Hu J; Zheng P; Lv Y; Liu H; Zhang G; Jiang H
J Oncol; 2023; 2023():8537036. PubMed ID: 36861062
[TBL] [Abstract][Full Text] [Related]
15. Low Expression of ZNF154 is Related to Poor Prognosis in Gastric Cancer.
He J; Huang J; Tang G; Wang P; He M; Wei S
Cancer Manag Res; 2022; 14():659-672. PubMed ID: 35210862
[TBL] [Abstract][Full Text] [Related]
16. Systematic Elucidation of the Aneuploidy Landscape and Identification of Aneuploidy Driver Genes in Prostate Cancer.
Peng Y; Song Y; Wang H
Front Cell Dev Biol; 2021; 9():723466. PubMed ID: 35127694
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation: A Promising Approach in Management of Alzheimer's Disease and Other Neurodegenerative Disorders.
Kaur G; Rathod SSS; Ghoneim MM; Alshehri S; Ahmad J; Mishra A; Alhakamy NA
Biology (Basel); 2022 Jan; 11(1):. PubMed ID: 35053088
[TBL] [Abstract][Full Text] [Related]
18. hsa_circ_0001275 Is One of a Number of circRNAs Dysregulated in Enzalutamide Resistant Prostate Cancer and Confers Enzalutamide Resistance In Vitro.
Lim MCJ; Baird AM; Greene J; McNevin C; Ronan K; Podlesniy P; Sheils O; Gray SG; McDermott RS; Finn SP
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34945002
[TBL] [Abstract][Full Text] [Related]
19. Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.
Kukkonen K; Taavitsainen S; Huhtala L; Uusi-Makela J; Granberg KJ; Nykter M; Urbanucci A
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283056
[TBL] [Abstract][Full Text] [Related]
20. Promoter Methylation of
Daniunaite K; Bakavicius A; Zukauskaite K; Rauluseviciute I; Lazutka JR; Ulys A; Jankevicius F; Jarmalaite S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
